| Issuer | % of Class | Filed |
|---|---|---|
|
Portage Biotech Inc.
13D/A
Amendment 3
ALP · G7185A136
|
16.7% |
1/31/2025
Event 1/23/2025
|
|
Portage Biotech Inc.
13D/A
Amendment 2
ALP · G7185A136
|
13.8% |
12/19/2024
Event 6/16/2020
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.